Where can I buy MRMD shares?
Shares of MRMD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here.
Is Marimed efficiently growing its dividend?
MariMed does not have a long track record of dividend growth. In the past three months, MariMed insiders have not sold or bought any company stock. 19.95% of the stock of MariMed is held by insiders. A high percentage of insider ownership can be a sign of company health.
Is MRMD stuck in a narrow trading range?
Until and unless cannabis is legalized on a federal basis where legal cannabis companies will have access to banking services, smaller MSO's like MRMD will be stuck in a narrow trading range.
Did MRMD buy kind Therapeutics?
Sign in to post a message. Good news out!! One of the companies (Kind Therapeutics) that MRMD has been managing for a while now and Bob has alluded to multiple times about bring into MRMD, well they finally bought them. This is one of two he has mentioned. Together he said it would push them up to $200 million revenue.
Is MRMD a good stock to buy?
Valuation metrics show that MariMed Inc. may be undervalued. Its Value Score of A indicates it would be a good pick for value investors. The financial health and growth prospects of MRMD, demonstrate its potential to outperform the market.
Will MRMD stock go up?
Marimed Inc (OTCQX US:MRMD) The 1 analysts offering 12-month price forecasts for Marimed Inc have a median target of 1.50, with a high estimate of 1.50 and a low estimate of 1.50. The median estimate represents a +174.98% increase from the last price of 0.55.
Is MRMD an OTC stock?
MRMD | MariMed Inc. Stock Overview (U.S.: OTC) | Barron's.
Where can I buy MRMD stock?
Shares of MRMD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Should I buy or sell MariMed stock right now?
2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for MariMed in the last twelve months. There are currently 2...
What is MariMed's stock price forecast for 2022?
2 brokerages have issued twelve-month target prices for MariMed's stock. Their forecasts range from $2.25 to $2.25. On average, they predict MariMe...
How has MariMed's stock performed in 2022?
MariMed's stock was trading at $0.8650 at the beginning of the year. Since then, MRMD stock has decreased by 31.8% and is now trading at $0.59. Vi...
Are investors shorting MariMed?
MariMed saw a increase in short interest during the month of May. As of May 15th, there was short interest totaling 55,100 shares, an increase of 3...
How were MariMed's earnings last quarter?
MariMed Inc. (OTCMKTS:MRMD) released its quarterly earnings results on Wednesday, March, 16th. The company reported ($0.02) EPS for the quarter, mi...
What guidance has MariMed issued on next quarter's earnings?
MariMed issued an update on its FY 2022 earnings guidance on Tuesday, June, 7th. The company provided earnings per share guidance of for the period...
Who are MariMed's key executives?
MariMed's management team includes the following people: Mr. Robert N. Fireman , Chairman, Pres & CEO (Age 73, Pay $250.19k) Mr. Jon R. Levine ,...
Who are some of MariMed's key competitors?
Some companies that are related to MariMed include Sundial Growers (SNDL) , True Drinks (TRUU) , Ascend Wellness (AAWH) , Canopy Rivers (RIV) ,...
What other stocks do shareholders of MariMed own?
Based on aggregate information from My MarketBeat watchlists, some companies that other MariMed investors own include KushCo (KSHB) , OrganiGram...
About MariMed
Headlines
MariMed, Inc. engages in direct owning of cannabis licenses and management of seed-to-sale operations. It focuses on the development, operation, management, and optimization of facilities for the cultivation, production, and dispensing of medicinal and recreational cannabis and cannabis-infused products. The company was founded by Robert N.
MariMed (OTCMKTS:MRMD) Frequently Asked Questions
Can you own more than one cannabis license in Maryland? - Baltimore Business Journal - Baltimore Business Journal
MariMed (OTCMKTS:MRMD) Price Target and Consensus Rating
1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for MariMed in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" MariMed stock. View analyst ratings for MariMed or view top-rated stocks.
Analyst Price Target Consensus
MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy).
Analyst Ratings By Month
Sign-up to receive the latest news and ratings for MRMD and its competitors with MarketBeat's FREE daily newsletter.
Average Share Price and Price Target by Month
The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
MariMed (OTCMKTS:MRMD) Analyst Ratings Frequently Asked Questions
The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target.
